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Abstract 
The hypothesis was that owing to their high bioavailability, zinc oxide nanoparticles (NanoZnO) can 
effectively replace (Zn) salts and reduce Zn excretion with faeces. The objective of this study was to 
investigate the effects of NanoZnO on the development of chicken embryos, the growth of broiler chickens, 
and Zn excretion with faeces. At day 1 of incubation, 120 eggs were randomly divided between a control 
group (not injected) and groups injected with a hydrocolloid of NanoZnO in increasing concentrations (50, 
100, 500 mg/L). At day 19 of incubation, no differences were observed in the bodyweight, but 100 and 500 
mg/L affected liver and heart weights, indicating that high levels of NanoZnO may induce differential organ 
development. In the subsequent experiment, 308 chickens were randomly divided into six groups. The 
control diet was supplemented with 55 mg Zn/kg (standard level), the 0 group received no Zn supplement, 
and groups fed NanoZnO received 25%, 50%, 75%, and 100% of the standard level. The 100% replacement 
of ZnO with NanoZnO increased the chickens’ bodyweight compared with the standard level of ZnO, but to 
the same level as the diet without ZnO supplementation. Furthermore, NanoZnO did not reduce the content 
of Zn in faeces, which was only significantly lower in the group without ZnO supplementation in comparison 
with other groups. The results indicate that the replacement of ZnO with NanoZnO had no negative effects 
on chicken growth. Compared with ZnO, NanoZnO did not reduce Zn excretion with faeces. 
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Introduction 
Nanoparticles are increasingly being considered for inclusion in formulated diets and supplementary 
nutrition for livestock production. The biological advantages of nano nutraceuticals include greater 
bioavailability owing to formation of micelles for absorption with lower residence in the intestinal tract, less 
excretion via the faeces, and easier movement across membranes (Gopi et al., 2017). Zinc is an essential 
supplement in poultry diets and plays crucial roles in the regulation of growth, the immune system and 
reproduction. 
Nanoparticles of Zn, primarily zinc oxide nano particles (NanoZnO) are potential alternatives to 
inorganic and organic Zn sources, specifically as an enhancer of broiler growth performance, as reviewed by 
Swain et al. (2016) and indicated by Fathi (2016), Asheer (2017), Badawi and Behairy (2017), Ali et al. 
(2017) and Bami et al. (2018). However, although the chickens supplemented with NanoZnO had a higher 
body gain and better feed conversion rate (FCR) than birds without Zn supplement, the growth performance 
was not different between groups fed with different Zn sources (inorganic, organic and nano) (Badawi et al., 
2017). The results of growth responses are not consistent, and render it difficult to draw general conclusions, 
largely owing to the lack of characterization (size, shape) of these nanoparticles and the varying content of 
Zn in dietary feed ingredients.  
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Post-hatch survival, growth and development are continuations of embryonic survival, growth and 
development, which are dependent on the nutrients in the yolk and albumen that are available to the 
developing embryo. To this effect, nano-copper (NanoCu) can replace copper (Cu) salts effectively in 
embryonic and post-hatch health and growth (Mroczek-Sosnowska et al., 2015a, 2015b; Mroczek-
Sosnowska et al., 2017; Scott et al., 2016; Scott et al., 2017; Sawosz et al., 2018; Scott et al., 2018). 
This research pursued the hypotheses that NanoZnO does not affect embryo growth and that 
NanoZnO could replace Zn salts as a health and growth promoter and, given their high reactivity and 
bioavailability, may reduce the content of Zn in faeces. The objective of the study was to establish whether 
NanoZnO could replace ZnO supplement in the diets of broilers, reducing excretion of Zn into the 
environment. 
 
Materials and Methods 
Ethical approval for this research is documented in I.dz.Ike 46/2015, Warsaw University of Life 
Sciences. 
NanoZnO powder (99.8% purity) was purchased from Sky Spring Nanomaterials Inc., Houston, USA, 
(Product no. 8410DL). For characterization, nanoparticles were suspended in Milli-Q water at a 
concentration of 50 mg/L water. The size and shape of the nanoparticles were determined with a JEM-
2000EX Transmission Electron Microscope at 80 keV (JOEL, Tokyo, Japan). The zeta potential was 
measured in a colloidal solution of 50 mg/L NanoZnO using Zetasizer Nano ZS, model ZEN3500 (Malvern 
Instruments, Worcestershire, UK). Each sample was measured after 120 seconds of stabilization at 25 °C, in 
20 replicates. Furthermore, colloidal impurities were determined using a Z-5300 polarised flame atomic 
absorption spectrometer (Hitachi-Science & Technology, Tokyo, Japan). 
The study consisted of Phases 1 and 2, in which Phase 1 examined the effects of NanoZnO in 
developing embryos, and Phase 2 examined the effects on post-hatch growth and development. 
In Phase 1, 120 eggs were randomly divided into four groups of 30 eggs per group. The hydrocolloids 
of NanoZnO were injected at the first day of incubation in concentrations 50, 100 and 500 mg/L. The control 
group (C) was not injected. At 19 days of incubation, the body and organ weights and biochemical indices of 
blood serum were measured. The administration of the NanoZnO incubation procedure and evaluation of 
embryo growth were performed as described by Pineda et al. (2013). 
In Phase 2, given that Zn nanoparticles in powder form were dusty and were added to the basal diets 
(Table 1) feeds in small quantities, it would have been difficult to obtain a homogeneous feed mixture. This 
limitation was overcome by mixing the NanoZnO with starch as a carrier before being added to the diets. 
NanoZnO powder and starch were suspended in ultrapure water in the proportion 1: 100 (NanoZnO: starch, 
w/w) and were subsequently dried to powder with a dry matter content not less than 90%. The NanoZnO and 
starch complex was then added to a premix (Rovmix Broiler Grower, 0.5%, DSM) and the premix (Table 2) 
was added to the basal diets. Dry matter, nitrogen, crude fat, crude fibre and energy contents were 
determined in feed samples (Pineda et al., 2012). 
Day-old Ross 308 chicks were obtained from a commercial hatchery and were randomly divided into 
six groups of six birds each, with a treatment allocated to a group, and six replicates in a treatment. The 
treatments of this post-hatch growth phase were designed to include a positive control (C) of 55 mg/kg ZnO 
in the diet as the standard that was in the mineral-vitamin premix, a group without ZnO, which received no 
Zn supplement (0) and groups that were fed with complexes of NanoZnO and starch received 25%, 50%, 
75%, and 100% of the standard level of Zn used in the control group (Table 3). The calculated total levels of 
exposure to dietary Zn were 114 and 59 mg/kg provided as ZnO, and 72.8, 86.5, 100 and 114 mg/kg 
provided as NanoZnO. The treatment period was from day 1 for 42 days. 
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Table 1 Ingredients and chemical composition of the basal starter and grower diets 
 
Ingredients (%) Starter (1 - 14 days) Grower (15 - 42 days) 
   
Wheat 45.10  47.50  
Soybean meal 25.65  22.00  
Maize 10.00  10.00  
Rape meal 10.00  10.00  
Soybean oil 5.23  7.19  
Dicalcium phosphate 2.25  1.54  
Alimet 88% 0.33  0.27  
L-lysine hydrochloride 98% 0.24  0.21  
Sodium chloride  0.21  0.22  
Chalk 0.20  0.32  
Sodium carbonate 0.15  0.10  
L-Threonine 0.14  0.15  
Mineral-vitamin premix  0.50  0.50  
Analysed chemical composition (%) 
Crude protein  21.70  19.42  
Crude fat  4.95  6.73  
Crude fibre  3.32  3.37  
Metabolizable energy, calculated (MJ/kg DM) 12.56  13.31  
     
 
 
The chickens were kept in groups during the first week and then individually in metabolic cages until 
they were 42 days old. The temperature was 32 °C in the first week, and lowered 2 °C weekly to 20 °C. The 
average humidity was 60% and 24-hour lighting was applied. The birds had free access to water and were 
fed ad libitum. The applied feed mixtures were starter for chickens 1 - 14 days and grower for 15 - 42 days 
(Table 2). Bodyweight (BW) was recorded at 1, 14, 35 and 42 days. The feed intake was registered daily as 
total values for each group. Individual excreta were collected daily over the period 28 to 35 days to 
determine the amount of Zn excreted.  
The animals were euthanised at 42 days following a 12 hour fast. Carcass yield (%) and the weight 
yield of leg and breast muscles, gizzard, liver, heart and adipose tissue were measured following 24-hour air 
chilling at 4 °C. The tissue samples, organs and excreta (n = 6 per group) were kept at -80 °C for further 
analyses. The Zn content in the feed, breast muscle, liver and femoral bone at 42 days, and in excreta (28 to 
35 days) was determined using a Z-5300 polarized flame atomic absorption spectrometer (Hitachi High-Tech 
Science Corporation, Tokyo, Japan).  
The data distribution was evaluated using the Shapiro-Wilk test. Data were normally distributed and 
the results were analysed with one-way analysis of variance (ANOVA) using Statgraphics Centurion XVI 
software (StatPoint Technologies, Inc., Warrenton, Virginia, USA) at a significance level of P <0.05. 
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Table 2 Composition of the mineral-vitamin premix to which zinc was added to administer treatments 
 
Ingredient Unit Quantity 
   
A (retinol acetate) IU/kg 2 200 000  
D3 (E671) IU/kg 500 000  
E (di-alpha-tocopherol acetate) mg/kg 10 000  
D (D-pantothenate calcium) mg/kg 2 722  
K3 (MNB) mg/kg 500  
B1 (thiamine mononitrate) mg/kg 400  
B2 (riboflavin) mg/kg 1400  
B6 (pyridoxine hydrochloride) mg/kg 800  
B12 (cyanocobalamin) μg/kg 400  
Niacin (nicotinic acid) mg/kg 8 000  
Folic acid mg/kg 200  
Biotin μg/kg 30 000  
Choline chloride mg/kg 60 000  
Copper mg/kg    
Zinc (zinc oxide) Amount depending on the treatment applied 
Manganese (manganese oxide) mg/kg 14 000  
Iodine (calcium iodate) mg/kg 120  
Selenium (sodium selenate) mg/kg 70.0  
Iron (iron sulphate) mg/kg 9 000  
Citric acid mg/kg 19.0  
Etoxyquin mg/kg 34.8  
Propyl gallate mg/kg 5.4  
Calcium carbonate 25.07% g/kg 251  
Magnesium 0.22% mg/kg 2200  
    
 
 
Table 3 Zinc sources and content of zinc oxide and nano-zinc oxide to be used in the experimental diets  
 
Zinc (Zn) source  Zinc oxide  Nano-zinc oxide 
     
Zn (%) of standard level1  100 0   25% 50% 75% 100% 
Zn (mg/kg) in premix  11000 0   2750 5500 8250 11000 
Zn supplement (mg/kg) diet2  55 0   13.8   27.5  41.3  55.0  
Zn total (mg/kg) diet3  114 59   72.8  86.5  100.0  114.0  
              
1 Level of Zn reduction compared with the standard level of 55.0 mg/kg diet: 100%  
2 Level of Zn supplemented from premix in a diet  
3 Total level of Zn from premix + feed ingredients in the grower diet 
 
 
Results 
NanoZnO were slightly angular, rounded or elongated with an average size of 37 nm (10 - 70 nm) 
(Figure 1). The specific surface area was 30–50 m2/g. The mean zeta potential of the colloid was -32 mV, 
which indicated an intermediate stability of the solution. The total impurities were below 0.01%.  
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Figure 1 Image of zinc oxide nanoparticles by transmission electron microscopy 
 
 
Live embryos at 19 days of incubation constituted 67% in the NanoZnO-treated groups compared with 
73% in the control group. Bodyweights were not significantly different between groups (Table 4). However, 
groups treated with 100 and 500 mg/L had significantly higher heart weights than the other groups, while 
liver weights were lower in NanoZnO groups compared with the control. 
 
 
Table 4 Pre-hatch embryo and organ weights of chicks at day 19 of incubation 
 
Treatment1 (mg/L) Embryo, g Heart, g Liver, g 
    
0 (C) 43.9  0.44B  1.21Aa  
50 41.2  0.36B  0.95B  
100 43.3  0.51A  1.13A  
500 42.1  1.13A  1.03b  
SE 1.0  0.03  0.04  
P-value 0.20  0.005  0.000  
       
1 C: control; treated with 50, 100 and 500 mg/kg of ZnO nanoparticles 
a, b Significant differences at P ≤0.05; A,B Significant differences at P ≤0.01 
 
 
The only differences in blood biochemical parameters were higher concentrations of alanine 
aminotransferase (ALT) and lower triglycerides (TRG) in groups treated with 100 and 500 mg/L of NanoZnO 
(Table 5). 
Bodyweight at 35 days did not differ significantly among the groups. At 42 days, the BWs of the ZnO- 
supplementation (0) and the 100% NanoZnO groups were significantly higher than the control. However, BW 
did not differ between 0 and NanoZnO groups (Table 6). Feed conversion ratio was measured on a group 
basis, which prevented statistical comparisons, but numerically FCR was higher (1.72) in the control relative 
to other groups (1.63). No mortality was recorded. 
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Table 5 Biochemical indices in the blood serum of chicken embryos as affected by level of supplementation 
with zinc oxide nanoparticles 
 
 Treatment1 
SE P-value  Control 50 100 500 
       
AST (U/l) 133A 122A 72.0B 122A 17.0 0.017 
ALT (U/l) 11.6B 9.90B 20.6A 17.0A 1.71 0.000 
ALP (U/l)  2222 2284 2540 2444 254.4 0.619 
Glc (mmol/l) 277 263 260 249 10.4 0.154 
Cr (mmol/l) 0.31ab 0.37a 0.27b 0.32ab 0.271 0.014 
TP (mmol/l) 20.5 19.5 22.5 17.5 2.69 0.415 
ALB (mmol/) 9.50 9.50 10.0 9.50 1.141 0.970 
TC (mmol/l) 360 390 415 334 22.4 0.020 
TRG (mmol/l) 84.4A 86.7A 71.9B 71.4B 3.70 0.001 
LDH (U/l) 655 691 628 660 37.9 0.528 
Ca (mmol/l) 9.00 10.2 9.70 9.60 0.492 0.246 
P (mmol/l) 6.51 5.82 5.71 5.47 1.053 0.051 
       
NanoZnO: zinc oxide nanoparticles , AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline 
phosphatase, Glc: d-glucose, Cr: Creatinine, TP: total protein, ALB: albumin, TC: number of white blood cells, TRG: 
triglycerides, LDH: lactate dehydrogenase, Ca: calcium, P: phosphorus 
1 C: control; and treated with 50, 100 and 500 mg/kg of ZnO nanoparticles 
a, b Significant differences at P ≤0.05; A, B Significant differences at P ≤0.01 
 
 
Table 6 Weights of chickens (g) over time as affected by level of supplementation with zinc oxide 
nanoparticles 
 
Treatment1  
Age (days) 
0 14 35 42 
     
C (55 mg/kg) 45  417  1936  2425b  
0% 43  376  2014  2612a  
25% 46  370  1927  2486ab  
50% 44  408  1975  2516ab  
75% 44  415  2094  2652ab  
100% 44  412  2063  2706a  
SEM 1  16  84  100  
P-value 0.665  0.192  0.703  0.042  
         
1 C: control; 0: without zinc oxide (ZnO) nanoparticles; 25%, 50%, 75%, and 100% in groups provided with ZnO 
nanoparticles in proportion to the control 
a, b Significant differences at P ≤0.05 
 
 
The analysis of carcasses showed that the Zn content of leg muscle was highest in the control and 
in the 0 group. The dressing percentage and the content of breast muscle and giblets were not affected 
(Table 7). 
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Table 7 Dressing percentage and carcass content of chickens (%) as affected by level of supplementation 
with zinc oxide nanoparticles 
 
Treatment1 Dressing percentage 
Muscle  Giblets 
Breast Leg  Gizzard Liver Heart 
        
C (55 mg/kg) 79.1  27.5  20.0a   1.63  2.58  0.69  
0% 80.6  27.1  20.0a   1.77  2.05  0.61  
25% 77.4  26.5  18.6ab   1.82  2.05  0.61  
50% 77.9  24.9  16.2b   1.68  2.19  0.93  
75% 78.0  26.6  16.7b   1.84  2.33  0.72  
100% 76.7  27.6  18.3ab   1.35  2.08  0.67  
SE 1.2  1.2  0.8   0.19  0.20  0.06  
P-value 0.293  0.626  0.022   0.512  0.414  0.054  
              
1 C: control; 0: without zinc oxide (ZnO) nanoparticles; 25%, 50%, 75% and 100% in groups provided with ZnO 
nanoparticles in proportion to the control 
a, b Significant differences at P ≤0.05 
 
 
Zinc concentration in breast muscle at 42 days did not differ significantly among the groups (Table 
8). However, the liver and femoral bone showed some differences, although these were inconsistent. The 
lowest concentration in faeces was observed in chickens that did not receive the ZnO supplement and 
highest in chickens that received 75 and 100% of Zn level and in the control.  
 
 
Table 8 Zinc content (mg/kg DM) of tissues and faeces from chickens provided different levels of dietary 
supplementation with zinc oxide nanoparticles  
 
Treatment1 Breast muscles Liver Femoral bone Faeces 
     
C (55 mg/kg) 34.0  130b  105d  281AD  
0% 34.6  164a  98.1Bb  164B  
25% 30.8  160a  113a  255AE  
50% 33.0  133ab  108abcd  243AC  
75% 25.0  121b  117a  293ADF  
100% 34.2  105b  119Ac  303ADF  
SE 4.3  12.0  4.3  8.6  
P-value 0.627  0.031  0.040  0.000  
         
1 C: control; 0: without zinc oxide (ZnO) nanoparticles; 25%, 50%, 75%, and 100% in groups provided with ZnO 
nanoparticles in proportion to the control 
a-d Significant differences at P≤0.05; A-F Significant differences at P ≤0.01  
 
 
The treatments had no effects on the biochemical indices of the blood serum (Table 9). 
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Table 9 Biochemical indices in the blood serum of chickens provided different levels of dietary 
supplementation with zinc oxide nanoparticles 
 
Treatment1 AST, U/l ALT, U/l Glc, mmol/dl Urea, mg/dl TP, g/l ALB. g/l TRG, mg/dl 
        
C (55 mg/kg) 487  19.7  226  8.73  24.0  16.7  22.2  
0% 511  21.2  204  6.53  26.0  16.6  20.5  
25% 508  20.7  199  9.20  23.3  15.3  19.5  
50% 485  20.3  191  8.13  24.0  15.0  18.6  
75% 429  22.9  194  7.61  24.2  16.0  18.5  
100% 417  19.0  188  7.33  24.0  15.3  20.2  
SE 50  3.2  10  0.97  0.8  0.6  4.2  
P-value 0.682  0.416  0.175  0.094  0.298  0.333  0.987  
               
1 C: control; 0: without zinc oxide (ZnO) nanoparticles; 25%, 50%, 75%, and 100% in groups provided with ZnO 
nanoparticles in proportion to the control 
AST: aspartate aminotransferase; ALT: alanine aminotransferase, Glc: glucose; TP: total protein; ALB: albumins; TRG: 
triglycerides 
 
 
Discussion 
In Phase 1, administration of NanoZnO at the beginning of embryogenesis had no effect on BW, but 
increased the heart weight and decreased the liver weight of embryos at 19 days. The lack of influence on 
BW at hatch was also demonstrated by Josuha et al. (2016), who injected NanoZnO at 18 days of 
incubation, and by Hassan (2018) when the injection took place at the beginning of incubation. The 
percentage of live embryos was lower in the NanoZnO treated groups than in the Control. This finding, 
however, is not congruent with those of Josuha et al. (2016) and Hassan (2018), who found no differences in 
hatchability, albeit using smaller doses of Zn nanoparticles. Whether the injection per se could affect the 
hatchability cannot be answered no group was injected with a placebo, but Hassan (2018) demonstrated no 
differences between embryos administered with nanoparticles and those that were not injected or were 
injected with phosphate buffered saline.  
Comparable results for the effect of NanoZnO on organ weights in the developing embryo could not be 
traced in the literature. The biochemical indices of blood serum were different only for ALT with an elevated 
level, and decreased TRG level in the 100 and 500 mg/L groups. These changes were within the normal 
range for chickens (Chattopadhyay et al., 2006; Hassan, 2018). The changes are an interesting 
phenomenon since the ALT was increased significantly in the 100 and 500 mg/L treatments, and the ratios of 
AST to ALT, which indicates clinical health in liver function, were 11.5, 12.3, 3.5, and 7.2 for the control and 
groups that were injected with 50, 100, and 500 mg/L, respectively. This decreasing ratio, aligned with the 
lower liver mass and increased heart mass, indicated that the higher levels of NanoZnO may induce 
differential organ development in chicken embryos. Chicken embryos are highly sensitive models for testing 
potential toxic effects of injected substances by monitoring total and differential organ development rates and 
survivability of the embryos (Korhonen et al., 1982; Sawosz et al., 2014; Lucht et al., 2018). 
In Phase 2, the chickens were kept in metabolic cages. Consequently, the number of animals was 
limited. However, the experiment was not a performance study, but it included individual measurements of 
the content of Zn in faeces, requiring individual cages for quantitative sample collection. The feed intake and 
FCR were recorded on a group basis. The control group was supplemented with a standard level of 55 mg 
Zn per kg of feed, as recommended by the NRC (1994). The group without ZnO did not receive Zn 
supplementation, while the other groups were administered with NanoZnO in incremental proportions of the 
control (55 mg/kg). 
There was no clear indication of differences in BW at 42 days since treatments 0%, 25%, 50%, 75%, 
and 100% did not differ. However, the treatment with 100% of NanoZnO significantly increased BW 
compared with the standard level of ZnO. Several reports show enhanced growth performance (Lina et al., 
2009; Ahmadi et al., 2013; Mishra et al., 2014; Zhao et al., 2014; Khah et al., 2015; Mohammadi et al., 2015; 
Fathi, 2016; Sahoo et al., 2016; Hassan, 2018), but others show no effects of Zn nanoparticles on BW (Lina 
et al., 2009; Asheer, 2017; Bami, 2018). The literature is conflicting, and it is impossible to explain 
incongruence, which might be attributed to the type, size and dose of nanoparticles, experimental design, 
and differences in feeding and management of chickens. 
Łukasiewicz et al., 2020. S. Afr. J. Anim. Sci. vol. 50 117 
 
 
The numeric values of FCR indicate that this was improved in the group without ZnO supplement and 
in all NanoZnO groups compared with the control group. Improved FCR had been demonstrated by Ahmadi 
et al. (2013), Zhao et al. (2014), Fathi (2016) and Sahoo et al. (2016) when comparing increased doses of 
NanoZnO with the standard supplement of Zn. However, when inorganic Zn was replaced with NanoZnO (25 
- 100% replacement), only the 100% replacement reduced FCR (Asheer, 2017).  
It is striking that BW and FCR, although improved by NanoZnO supplementation, were not different 
from the birds fed without ZnO. The feed ingredient provided 59 mg Zn/kg diet, which was sufficient to meet 
the birds’ requirements. In the control, the total amount of Zn was 114 mg/kg (feed ingredients 59 mg/kg + 
ZnO supplement 55 mg/kg), which was probably too high, but nevertheless low enough to avoid causing 
harmful health effects. The diets with NanoZnO provided increasing levels of Zn (from 73 to 114 mg/kg), 
causing higher body gain and superior FCR to the control group, but no different from the group without ZnO 
supplementation. This might indicate that the replacement of ZnO with NanoZnO can enhance chicken 
performance, but that it is not necessary when the supply of Zn from feed ingredients covers Zn 
requirements. The feed ingredients used in the present diet are standard compounds, suggesting that the 
results might be applicable to commercial poultry mixtures, which provide enough Zn from feed ingredients. 
Nevertheless, this postulate has to be justified in extended performance experiments. 
The effect of NanoZnO on dressing percentage has been reported as being both positive (Lina, 2009; 
Khah et al., 2015) and negative (Sahoo et al., 2016). The present results indicated an absence of effects on 
dressing percentage and the carcass content of breast muscle and giblets at 42 days. However, the content 
of leg muscle decreased in NanoZnO-treated groups. Again, it is difficult to compare results from different 
methodologies, but the findings of Kahah et al. (2015) and Sahoo et al. (2016) showed no effects on the 
proportion of thigh. 
After absorption in the intestine, nanoparticles can enter the bloodstream and be stored in various 
organs and be distributed independently of the blood circulation (Anjum et al., 2016). In the present 
experiment, the content of Zn in breast muscle was generally lower in NanoZnO groups than in the control 
and 0 groups. The differences between Zn retained in the liver and femoral bone were not conclusive. Sahoo 
et al. (2014) noted that NanoZnO could increase Zn content in the tibia bone, liver and blood serum, but that 
study is not directly comparable with the present study. 
The content of Zn in faeces was significantly lower in the group without ZnO supplementation, relative 
to the other groups, which did not differ significantly. The administration of NanoZnO did not reduce Zn 
excretion in comparison with the control group. The increased excretion in the faeces with increasing 
supplementation of NanoZnO can be ascribed to residual non-absorbed dietary Zn in the digestive tract plus 
endogenous Zn that is excreted via the liver and biliary tract and kidneys. As noted, individual feed intake 
could not be recorded, nor could the total exposure to dietary Zn calculated. However, the non-significant 
differences in faecal Zn between groups C, 25%, 50%, 75%, and 100% could indicate similar homeostatic 
processes between the treatments. The deduction is that homeostasis of Zn was not dependent on the level 
of NanoZnO intake. 
The biochemical parameters of the blood serum were not affected. The present results correspond 
with findings by Fathi (2016) and Hassan (2018), but contradict those of Ahmadi et al. (2013), Mishra et al. 
(2014), and Sahoo et al. (2014), who did identify some effects. As in performance, the literature is 
inconsistent. Furthermore, there was no mortality in any of the groups, indicating good health status of all 
birds. 
It emerged from Phases 1 and 2 that differential development may have been induced in embryonic 
development that was carried through to the post-hatch growth and development. The embryos showed 
increased liver and heart weights and the chickens showed lighter livers with increasing NanoZnO, though 
non-significant, and significant differential development of the leg muscle in which the 50%, 75%, and 100% 
treatments were lower that the C and 0 groups. The biochemical indices also showed interesting tendencies. 
It would appear, though the results do not show significance, that the NanoZnO could have an effect at 
mitochondrial level. The embryos show decreasing TP and increasing Cr. Using these few values, the 
correlation is -0.6, and reciprocal. Because the leg muscle is lower percentagewise, this may indicate 
differential growth that is affecting red muscle fibre. In early development, all the muscle fibres have 
the characteristic of red aerobic muscles. As development advances in chickens, a differentiation occurs with 
the breast muscles, which become white muscle types, glycolytic, with the leg muscle, for example the 
gastrocnemius, retaining red muscle fibre characteristics. 
 
Conclusion 
Injection of NanoZnO into eggs at the start of incubation did not affect BW, survival rate and health 
status of embryos in the final stage of embryogenesis. There was an indication that concentrations greater 
than or equal to 100 mg/L may induce differential organ development. In post-hatch growth, the replacement 
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of the standard level of ZnO (55 mg/kg) with 100% NanoZnO in the diet increased the chickens’ BW, but to 
the same level as in the group without ZnO supplementation. Furthermore, NanoZnO did not reduce the 
content of Zn in faeces, which was only significantly lower in the group without ZnO supplementation in 
comparison with other groups. The results indicate that the replacement of ZnO with NanoZnO has no 
negative effects on chicken growth.  
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